Rho Capital Partners

Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are IL, Anacor Pharmaceuticals In, RLOC, GNVC. These five stock positions account for 100.00% of RHO CAPITAL PARTNERS's total stock portfolio.
  • Reduced shares in these 3 stocks: Anacor Pharmaceuticals In (-$26.07M), IL, .
  • Sold out of its positions in VRNM.
  • As of Dec. 31, 2013, RHO CAPITAL PARTNERS has $195.19M in assets under management (AUM). Assets under management grew from a total value of $163.01M to $195.19M.
  • Independent of market fluctuations, RHO CAPITAL PARTNERS was a net seller by $30.85M worth of stocks in the most recent quarter.

RHO CAPITAL PARTNERS portfolio companies for December 2013 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
IL IntraLinks Holdings 47.06 -4.00% 7584296 12.11 9.37
Anacor Pharmaceuticals In 34.97 -27.00% 4067892 16.78 0.00
RLOC ReachLocal 17.95 2756966 12.71 10.09
GNVC GenVec 0.02 18036 2.33 2.66

Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS